One health
Communicable diseases remain one of the major causes of mortality worldwide. There are disparities in the numbers of individuals affected by disease between low-and-middle-income countries and those in developed nations. Microbes will play in important role in drug discovery: producing anticancer drugs and antimicrobials. Applying One Health principles, to understand the interaction of pathogens and the human host, development of diagnostics, treatments, and disease prevention, applied microbiologists can shape global health and wellbeing outcomes.
News
A pan-sRNome analysis identifies novel regulatory small RNAs involved in Pseudomonas aeruginosa virulence
A characterization of nine newly discovered sRNAs reveals their regulatory networks in quorum sensing, biofilm formation, and interbacterial competition in Pseudomonas aeruginosa.
Read story
NewsExpert consensus outlines 12 recommendations to prevent secondary mucormycosis after respiratory viral infections
The recommendations focus on defined high-risk patients, early viral testing and treatment, hospital infection control, and practical measures for resource-limited settings.
NewsNew study details the finding of the first known live kissing bug in Europe
Students taking a Medical Entomology class donned their detective hats and helped investigate what appears to be the first documented live kissing bug in Europe.
NewsNew research offers avenue to explore relationship between Alzheimer’s and HIV
Researchers have created an animal model that helps resolve questions about the relationship between HIV and Alzheimer’s disease (AD). The virus that drives the root cause of AD initiates a complex chain that, with other disease partners, drives nerve cell injury and cognitive impairments for AD pathology.
More One Health
News
Symposium commemorating the 50th anniversary of the discovery of the Hantaan virus successfully held
A symposium commemorating the 50th anniversary of the discovery of the Hantaan virus celebrated the historical achievement of the late Dr. Lee Ho-wang and reviewed the historical significance of Hantaan virus research, its results, and future infectious disease response strategies.
NewsHeatwaves inhibit antibiotic resistance in soils - but at a price
Heatwaves temporarily reduce the amount of resistance genes in the soil, but heat and droughts are also causing significant damage to soils and ecosystems. The temporary dip in resistance therefore does not mean that the health risks from antibiotic resistance disappear.
NewsProbiotic use surges - but microbiome-supportive food consumption stagnates
New research finds that probiotic supplement use has surged in the United States, while the consumption of microbiome-supportive foods has remained virtually unchanged.
NewsToxic tail: Biologists find a hidden weak spot in how bacteria build the tails they use to move
New research has uncovered a previously unknown vulnerability in how bacteria build the whip-like tails they use to move. Building these tails can put stress on the protective wall surrounding a bacterial cell, and uncovered systems bacteria use to keep that stress from becoming destructive.
NewsHelicobacter pylori exposure may be linked to more than 1 in 5 bowel cancer cases worldwide
Exposure to the stomach microbe Helicobacter pylori may be associated with more than 1 in 5 cases of bowel cancer worldwide, suggests an exploratory risk attribution study - and those born in more recent decades may be more at risk of the disease after exposure.
NewsBacterial trial fails to demonstrate early asthma prevention - prompting rethink of 'hygiene hypothesis'
A national clinical trial has found that treating young children with an oral bacterial extract did not reduce the risk of severe wheezing and respiratory illnesses that can precede asthma, potentially prompting researchers to rethink aspects of the hygiene hypothesis.
NewsVaccine protects against multiple fungal infections without hurting the gut
A vaccine created to battle multiple life-threatening fungal infections is successful in achieving protective immunity in pre-clinical animal models while also maintaining the biodiversity of the gut microbiome, according to a new study.
NewsFaster diagnostics, deeper insights: Researchers strengthen response to Ebola outbreaks
Two studies provide important insights into the challenges of responding to outbreaks - one demonstrates how diagnostic tests can be evaluated rapidly during an outbreak; the other investigates the biological properties of the 2026 BDBV strain and whether an existing Ebola vaccine could offer cross-protection.
NewsCommonly used cancer drugs boost MRSA antibiotics – new research
Scientists tested five anti-cancer drugs and revealed that four of them helped penicillin-type antibiotics to kill MRSA. These drugs interfere with the bacteria’s ability to make DNA, making the bacteria more vulnerable to the antibiotics.
NewsResearch explores why strep throat can linger, even after treatment with antibiotics
Streptococcal sore throat can linger even after treatment, turning otherwise healthy children into carriers. Using whole genome sequencing, researchers hope to discover why.
NewsMpox outbreak in 2022 caused by less severe form of the virus
The strain of Mpox behind the 2022 outbreak was a weakened form of the virus, which may have helped to spread it faster, a new study reports. The findings show that the virus acquired mutations before it spread globally.
NewsShould adults with autoimmune rheumatic conditions receive updated COVID-19 vaccines?
Adults with autoimmune rheumatic conditions who developed COVID-19 and received booster or updated (2023-2024) COVID-19 vaccines were less likely to be hospitalized for COVID-19 compared to those who received only the initial series vaccines or who were unvaccinated.
NewsRiver drinking water sources may face greater antibiotic resistance risks than reservoirs, study finds
A basin-wide study of 13 drinking water sources in China’s Poyang Lake region shows that water source type can strongly shape the occurrence and spread of antibiotics, antibiotic resistance genes, and resistant bacteria.
NewsHigh-dose flu vaccine beneficial for older people with lung disease
The risk of being hospitalised for flu or pneumonia can be reduced with a high-dose flu vaccine for older people with chronic lung disease, according to the combined results of two large clinical trials.
NewsHaving COVID-19 is associated with lower subsequent development of type 1 diabetes among those aged under 30 years
New research shows that people who have had COVID-19 have a lower, rather than higher, risk of subsequent development of type 1 diabetes (T1D). Furthermore, the effect is evident only in people who did not receive the SARS-CoV-2 vaccine.
OpinionHow Puerto Rico’s first microbiome research center can reshape global science collaboration
AMI’s Global Ambassador for the Americas, Dr. Filipa Godoy-Vitorino, Chair of the Department of Microbiology at the University of Puerto Rico, reveals why she is spearheading the planned Puerto Rico Center for Microbiome Sciences (PR-CMS)—the first of its kind in the region.
NewsMember Q&A: Harta Wedari on how AMI has opened up new opportunities and communities
Dr Ni Luh Putu Harta Wedari, a medical doctor and Clinical Microbiology Specialist from Bali, Indonesia reveals how engaging with AMI has expanded her international network and unveiled new opportunities.
NewsSmall bowel microbiome offers clues to women’s health
A new study has identified differences in the makeup and organization of the small bowel microbiome between women and men. One intriguing finding was a bacterial community containing Granulicatella, found only in women.